HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Abstract
Ketogenic diets are high in fat and low in carbohydrates, and have long been used as an anticonvulsant therapy for drug-intractable and pediatric epilepsy. Additionally, ketogenic diets have been shown to provide neuroprotective effects against acute and chronic brain injury, including beneficial effects in various rodent models of neurodegeneration. Huntington's disease is a progressive neurodegenerative disease characterized by neurological, behavioral and metabolic dysfunction, and ketogenic diets have been shown to increase energy molecules and mitochondrial function. We tested the effects of a ketogenic diet in a transgenic mouse model of Huntington's disease (R6/2 1J), with a focus on life-long behavioral and physiological effects. Matched male and female wild-type and transgenic mice were maintained on a control diet or were switched to a ketogenic diet fed ad libitum starting at six weeks of age. We found no negative effects of the ketogenic diet on any behavioral parameter tested (locomotor activity and coordination, working memory) and no significant change in lifespan. Progressive weight loss is a hallmark feature of Huntington's disease, yet we found that the ketogenic diet-which generally causes weight loss in normal animals-delayed the reduction in body weight of the transgenic mice. These results suggest that metabolic therapies could offer important benefits for Huntington's disease without negative behavioral or physiological consequences.
AuthorsDavid N Ruskin, Jessica L Ross, Masahito Kawamura Jr, Tiffany L Ruiz, Jonathan D Geiger, Susan A Masino
JournalPhysiology & behavior (Physiol Behav) Vol. 103 Issue 5 Pg. 501-7 (Jul 06 2011) ISSN: 1873-507X [Electronic] United States
PMID21501628 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • HTT protein, human
  • Huntingtin Protein
  • Nerve Tissue Proteins
  • Neuroprotective Agents
  • Nuclear Proteins
  • 3-Hydroxybutyric Acid
Topics
  • 3-Hydroxybutyric Acid (blood)
  • Age Factors
  • Animals
  • Diet, Ketogenic (methods, psychology)
  • Disease Models, Animal
  • Female
  • Humans
  • Huntingtin Protein
  • Huntington Disease (blood, diet therapy, genetics, physiopathology, psychology)
  • Kaplan-Meier Estimate
  • Longevity (drug effects)
  • Male
  • Maze Learning (drug effects)
  • Memory, Short-Term (drug effects)
  • Mice
  • Mice, Transgenic
  • Motor Activity (drug effects)
  • Nerve Tissue Proteins (genetics, physiology)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Nuclear Proteins (genetics, physiology)
  • Rotarod Performance Test (methods)
  • Sex Characteristics
  • Weight Loss (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: